Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-weeks results from the Dutch BioDay registry

Mendeley Data2026-04-18 收录

数据链接：

https://data.mendeley.com/datasets/j7mxzzbhc5 数据链接链接失效反馈

官方服务：

资源简介：

Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-weeks results from the Dutch BioDay registry

度普利尤单抗（Dupilumab）在日常临床实践的大型治疗难治性特应性皮炎（atopic dermatitis）患者队列中展现出长期疗效：来自荷兰BioDay登记处的52周研究结果

创建时间：

2020-09-04

Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-weeks results from the Dutch BioDay registry

资源简介：

相关数据集